Cite
MLA Citation
N. Jain et al.. “P1451: PRELIMINARY RESULTS FROM THE FLU/CY/ALEMTUZUMAB ARM OF THE PHASE I BALLI-01 TRIAL OF UCART22, AN ANTI-CD22 ALLOGENEIC CAR-T CELL PRODUCT, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) CD22+ B-CELL ALL.” HemaSphere, vol. 6, n.d., pp. 1333–1334. http://access.bl.uk/ark:/81055/vdc_100159756365.0x00000e